| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.4590 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.4900 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.4902 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.5064 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.5203 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 0.5569 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.6119 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.6215 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.6309 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.6568 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.6637 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.6817 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 0.6842 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.7063 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.7073 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.7270 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.7289 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.7296 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 0.7307 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.7364 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.7369 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.7466 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.7593 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.7658 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.7750 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.7819 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.7854 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.7884 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.7953 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8035 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8101 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8156 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8184 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8266 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8317 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8400 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8507 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8586 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8675 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 0.8732 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8739 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8763 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8766 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8792 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.8848 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.8849 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.8893 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8932 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.8977 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9067 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.9129 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 0.9168 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9189 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9215 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9215 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 0.9247 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9258 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9262 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9466 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 0.9518 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.9550 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9569 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9640 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9708 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9720 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9844 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9905 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 0.9950 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 0.9951 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 0.9990 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0000 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0010 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.0049 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.0066 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0125 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0235 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0327 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0433 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0489 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.0512 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0558 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0580 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0630 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.0632 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0738 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0752 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.0762 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.0814 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.0843 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0872 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.0916 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.1133 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.1162 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.1194 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.1250 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.1374 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.1393 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.1468 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.1575 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.1599 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.1640 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.1698 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.1812 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.1843 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.1913 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.1914 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.1950 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.1951 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.2001 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2082 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2149 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.2240 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.2297 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2320 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2320 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2412 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2449 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2500 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2532 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.2581 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.2608 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2632 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2694 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2750 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.2762 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.2771 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | uracil | 1.2793 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2812 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.2885 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | uracil | 1.3055 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.3066 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.3361 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.3367 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.4211 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.4230 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.4417 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.4441 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.5438 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.5595 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.5700 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | uracil | 1.6283 | scaled units | High-Dose | +47HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|